XEDAR activates the non-canonical NF-κB pathway

Biochemical and Biophysical Research Communications

Volumn 465, Issue 2, 2015, Pages 275-280

  Verhelst, Kelly ^a,b   Gardam, Sandra ^a,b   Borghi, Alice ^a,b   Kreike, Marja ^a,b   Carpentier, Isabelle ^a,b   Beyaert, Rudi ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Ectodermal dysplasia; EDA2R; Non canonical; Nuclear factor B; XEDAR

Indexed keywords

CIAP1 PROTEIN; DEUBIQUITINASE; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN A20; PROTEIN P100; PROTEIN P52; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; XEDAR RECEPTOR; CHUK PROTEIN, HUMAN; DNA BINDING PROTEIN; ECTODYSPLASIN A; EDA PROTEIN, HUMAN; EDA2R PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NF-KAPPA B KINASE; NUCLEAR PROTEIN; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN; TRAF3 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STABILITY; GENE MUTATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSIENT EXPRESSION; UBIQUITINATION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

DNA-BINDING PROTEINS; ECTODYSPLASINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B P52 SUBUNIT; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TNF RECEPTOR-ASSOCIATED FACTOR 6; XEDAR RECEPTOR;

EID: 84940461659     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.08.019     Document Type: Article

References (27)

1. B. Hoesel, and J.A. Schmid The complexity of NF-kappaB signaling in inflammation and cancer Mol. Cancer 12 2013 86
2. M.S. Hayden, and S. Ghosh Regulation of NF-kappaB by TNF family cytokines Semin. Immunol. 26 2014 253 266
3. M. Hinz, and C. Scheidereit The IkappaB kinase complex in NF-kappaB regulation and beyond EMBO Rep. 15 2014 46 61
4. S.C. Sun The noncanonical NF-kappaB pathway Immunol. Rev. 246 2012 125 140
5. L. Busino, S.E. Millman, L. Scotto, and et al. Fbxw7alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma Nat. Cell Biol. 14 2012 375 385
6. A. Fong, and S.C. Sun Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-kappa B2/p100 J. Biol. Chem. 277 2002 22111 22114
7. H. Fukushima, A. Matsumoto, H. Inuzuka, and et al. SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction Cell Rep. 1 2012 434 443
8. U. Senftleben, Y. Cao, G. Xiao, and et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway Science 293 2001 1495 1499
9. G. Xiao, E.W. Harhaj, and S.C. Sun NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100 Mol. Cell 7 2001 401 409
10. J. Hauer, S. Puschner, P. Ramakrishnan, and et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs Proc. Natl. Acad. Sci. U. S. A. 102 2005 2874 2879
11. J.Q. He, S.K. Saha, J.R. Kang, and et al. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway J. Biol. Chem. 282 2007 3688 3694
12. J.Q. He, B. Zarnegar, G. Oganesyan, and et al. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency J. Exp. Med. 203 2006 2413 2418
13. M. Bayes, A.J. Hartung, S. Ezer, and et al. The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative splicing and encodes ectodysplasin-A with deletion mutations in collagenous repeats Hum. Mol. Genet. 7 1998 1661 1669
14. M. Yan, L.C. Wang, S.G. Hymowitz, and et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors Science 290 2000 523 527
15. M.L. Mikkola The Edar subfamily in hair and exocrine gland development Adv. Exp. Med. Biol. 691 2011 23 33
16. A. Naito, H. Yoshida, E. Nishioka, and et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia Proc. Natl. Acad. Sci. U. S. A. 99 2002 8766 8771
17. S.K. Sinha, S. Zachariah, H.I. Quinones, and et al. Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor J. Biol. Chem. 277 2002 44953 44961
18. H.J. Coope, P.G. Atkinson, B. Huhse, and et al. CD40 regulates the processing of NF-kappaB2 p100 to p52 EMBO J. 21 2002 5375 5385
19. G. Liao, M. Zhang, E.W. Harhaj, and et al. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation J. Biol. Chem. 279 2004 26243 26250
20. G. Qing, Z. Qu, and G. Xiao Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100 J. Biol. Chem. 280 2005 40578 40582
21. L. Catrysse, L. Vereecke, R. Beyaert, and et al. A20 in inflammation and autoimmunity Trends Immunol. 35 2014 22 31
22. N. Yamaguchi, M. Oyama, H. Kozuka-Hata, and et al. Involvement of A20 in the molecular switch that activates the non-canonical NF-kappaB pathway Sci. Rep. 3 2013 2568
23. N. Kayagaki, Q. Phung, S. Chan, and et al. DUBA: a deubiquitinase that regulates type I interferon production Science 318 2007 1628 1632
24. K. Heyninck, S. Van Huffel, M. Kreike, and et al. Yeast two-hybrid screening for proteins interacting with the anti-apoptotic protein A20 Methods Mol. Biol. 282 2004 223 241
25. D.A. Prodi, N. Pirastu, G. Maninchedda, and et al. EDA2R is associated with androgenetic alopecia J. Invest. Dermatol. 128 2008 2268 2270
26. K. Newton, D.M. French, M. Yan, and et al. Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency Mol. Cell Biol. 24 2004 1608 1613
27. C. Tanikawa, C. Ri, V. Kumar, and et al. Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway Mol. Cancer Res. 8 2010 855 863